Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Triamcinolone for Diffuse Diabetic Macular Edema
NCT00309192Phase 3Completed
- Start
- Apr 2006
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone in diabetic macular edema (DME). Started Apr 2006; status: completed.
02
Drugs
triamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00309192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309192.